Switch to: References

Add citations

You must login to add citations.
  1. Ethical Analysis on the Application of Neurotechnology for Human Augmentation in Physicians and Surgeons.Soaad Hossain & Syed Ishtiaque Ahmed - 2021 - In Kohei Arai, Supriya Kapoor & Rahul Bhatia (eds.), Proceedings of the Future Technologies Conference (FTC) 2020. pp. 78-99.
    With the shortage of physicians and surgeons and increase in demand worldwide due to situations such as the COVID-19 pandemic, there is a growing interest in finding solutions to help address the problem. A solution to this problem would be to use neurotechnology to provide them augmented cognition, senses and action for optimal diagnosis and treatment. Consequently, doing so can negatively impact them and others. We argue that applying neurotechnology for human enhancement in physicians and surgeons can cause injustices, and (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Are intellectual property rights compatible with Rawlsian principles of justice?Darryl J. Murphy - 2012 - Ethics and Information Technology 14 (2):109-121.
    This paper argues that intellectual property rights are incompatible with Rawls’s principles of justice. This conclusion is based upon an analysis of the social stratification that emerges as a result of the patent mechanism which defines a marginalized group and ensure that its members remain alienated from the rights, benefits, and freedoms afforded by the patent product. This stratification is further complicated, so I argue, by the copyright mechanism that restricts and redistributes those rights already distributed by means of the (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases.J. Sonderholm - 2009 - Journal of Medical Ethics 35 (5):315-319.
    This paper deals with the question of how to price drugs for tropical diseases. The thesis defended in the paper is: (i) there should be no legal constraints on the profits pharmaceutical companies can make on their products for tropical diseases. In essence, (i) expresses the idea that drugs for tropical diseases should be treated as any other product on the free market and that the producers of these drugs should be allowed to sell their products at whatever price the (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations